ARK Invest's founder capitalized on recent market weakness to increase holdings in three of her flagship disruptive innovation picks, signaling continued conviction despite sector volatility.
As the Bank of Canada holds rates steady, speculative capital is sifting through junior resource stocks. We examine three micro-caps—a driller, an explorer, and an oil hopeful—navigating unique challenges and opportunities in early 2026.
In its Q4 2025 letter, Greenlight Capital revealed a new position in dental distributor Henry Schein (HSIC), arguing the stock presents an opportunity for operational improvement and shareholder returns, despite recent underperformance.
In a landmark deal, AstraZeneca has licensed a suite of next-generation weight-loss drugs from China's CSPC, aiming to challenge the dominance of Lilly and Novo Nordisk with longer-acting monthly injectables.
Despite reporting earnings that edged past expectations, Houlihan Lokey's shares fell 12% post-earnings. Analysts' long-term forecasts remain largely unchanged, signaling a 'steady-as-she-goes' assessment of the investment bank's prospects.
Newly launched oral weight-loss drug Wegovy from Novo Nordisk recorded more than 26,000 U.S. prescriptions in its second full week, signaling robust early demand as competition with Eli Lilly intensifies.
Amid market volatility, these three companies offering yields above 4% present a compelling case for income-focused investors, backed by strategic pivots and resilient business models.
Shares of Axos Financial (AX) have surged, closing at $94.64 and delivering strong returns over multiple timeframes. This momentum has reignited the debate among investors: is the stock still undervalued against its fair value estimate of $100.50, or has the market already priced in its future growth?
While major indices tread water ahead of key earnings, a segment of the market continues to buzz with activity. We examine three micro-cap companies—Hongli Group, Royalty Management, and CreateAI—whose financial profiles and strategic moves are capturing attention from investors willing to navigate the high-risk, high-reward penny stock arena.
JPMorgan reiterates its Overweight rating on ServiceNow (NOW) with a $215 price target, following checks with nine ecosystem partners. While growth expectations have moderated slightly, the firm finds AI is fueling expansion and mission-critical projects continue unabated.
The long-term strategic partnership will leverage IQVIA's data-as-a-service platform to unify and streamline commercial data across 59 countries, aiming to accelerate product launches and enhance decision-making for the pharmaceutical giant.
Freeman Gold Corp. (CVE:FMAN) surged 13% last week, with retail investors—who control 56% of the company—benefiting most alongside insiders. The significant retail ownership underscores their influence on corporate decisions in this junior mining firm.
Israeli authorities announce the reopening of the Rafah crossing this Sunday, ending a nearly two-year blockade of Gaza's sole passage to Egypt.
Israel announces the Rafah border crossing will reopen this Sunday for limited travel between Gaza and Egypt, marking a significant shift in access for the enclave's 2 million residents after an eight-month Israeli control of the vital gateway.
With major indices treading water after the Fed's steady rates, savvy investors are turning to overlooked small-cap stocks where insider buying signals conviction. We examine three companies where executives are backing their firms with their own capital.
With the Federal Reserve holding rates steady and economic signals mixed, investors are looking beyond the S&P 500 for growth. We analyze three under-the-radar companies—Tiptree, Slide Insurance, and Colony Bankcorp—that show strong fundamentals and strategic momentum as we head into 2026.
With major indices hovering near record levels and the Federal Reserve on hold, income-focused investors are turning to dividend payers for reliable returns. We analyze three standout stocks offering yields and stability as the market awaits tech earnings season.
Baldwin Insurance Group (BWIN) shares have faced significant pressure, dropping over 13% in a week. With a one-year loss of 45%, investors are questioning if the sell-off presents a buying opportunity or signals deeper issues. Our analysis digs into the valuation debate and key risks.
Klarna Group faces a dual challenge: surging commercial demand for its 'buy now, pay later' services and intensifying legal scrutiny over alleged IPO disclosure failures regarding credit risk. The stock's sharp decline shifts investor focus to upcoming quarterly results and credit quality metrics.
Align Technology is accelerating its expansion in Southeast Asia with new product launches and affordability programs, a strategic pivot as the company navigates competitive pressures and seeks to reignite investor confidence amid a challenging stock performance.
